1 / 8

Acquired Hemophilia Treatment Market by Product, by Application, by Geography, Size, Share, Growth, Global Trends, Indus

The types of traditional therapies used to treat acquired hemophilia areu00a0steroidu00a0treatment, cytotoxic therapy, and immunomodulatory therapy. The advancedu00a0treatmentu00a0segmentation includes recombinant activated factor VII/NovoSeven RT, recombinant porcine factor VIII, activated prothrombin complex concentrate (aPCC)/FEIBA, and desmopressin (DDAVP). Bypassing agents such as FEIBA and NovoSeven are used as first-line treatment for controlling bleeding. International recommendations have stated that anti-hemorrhagic treatments should be promptly administered in patients with critical bleeding where acquired hemophilia is confirmed, irrespective of factor VIII activity and inhibitor titer.

purushottamrajput786
Download Presentation

Acquired Hemophilia Treatment Market by Product, by Application, by Geography, Size, Share, Growth, Global Trends, Indus

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Acquired Hemophilia Treatment Market Acquired Hemophilia Treatment Market by Product, by Application, by Geography, Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027 Know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=144546

  2. Global Acquired Hemophilia Treatment Market Market synopsis: Theglobal acquired hemophilia treatment market size is projected to grow at a significant CAGR of over 6% market during the forecast period 2020-2027. The types of traditional therapies used to treat acquired hemophilia are steroid treatment, cytotoxic therapy, and immunomodulatory therapy. The advanced treatment segmentation includes recombinant activated factor VII/NovoSeven RT, recombinant porcine factor VIII, activated prothrombin complex concentrate (aPCC)/FEIBA, and desmopressin (DDAVP). Bypassing agents such as FEIBA and NovoSeven are used as first-line treatment for controlling bleeding. International recommendations have stated that anti-hemorrhagic treatments should be promptly administered in patients with critical bleeding where acquired hemophilia is confirmed, irrespective of factor VIII activity and inhibitor titer.

  3. Global Acquired Hemophilia Treatment Market Research Methoddolgy:

  4. Global Acquired Hemophilia Treatment Market Global Acquired Hemophilia Treatment Market Segmentation: By Product, 2018–2027 ($ Millon) • Traditional Therapy • Advanced Therapy • Desmopressin (DDAVP) • Recombinant Activated Factor VII/NovoSeven RT • Recombinant Porcine Factor VIII/Obizur • Activated Prothrombin Complex Concentrate (aPCC)/FEIBA By Application, 2018–2027 ($ Millon) • Pharmaceuticals • Food and Beverages • Feed Additives • Cosmetics • Others

  5. Global Acquired Hemophilia Treatment Market Global Acquired Hemophilia Treatment Market Segmentation: By Geography, 2018-2027 ($ Millon) • North America • Europe • Asia Pacific • Latin America (LATAM) • Middle East and Africa (MEA)

  6. Global Acquired Hemophilia Treatment Market List of Key Companies: • Baxalta, Inc • Baxter Healthcare Corporation • Bristol-Myers Squibb • Genentech, Inc. • Novo Nordisk A/S • Ferring B.V. • Sanofi SA

  7. Global Acquired Hemophilia Treatment Market By Region:

  8. Global Acquired Hemophilia Treatment Market Media Contact: Company Name: Research CorridorContact Person: Mr. Vijendra SinghEmail: sales@researchcorridor.comContact no: +91 989-368-5690 Follow Us:

More Related